VP1 and VP2 may covary in norovirus evolution, and sequence hypervariability of VP2 may be functionally driven.
Answers are grounded in this paper and cite their sources.
VP2 hypervariability may be functionally driven in GII.4 strains; leaves open evolutionary and vaccine implications pending human validation.
We report sequence hypervariability in the viral protein 1 (VP1) interaction domain of VP2 in the norovirus (NoV) genogroup II genotype 4 (GII.4) lineage on 3 levels: (i) the global evolution of pandemic/epidemic strains from the mid-1970s through post-2006, (ii) the local emergence of an epidemic strain, and (iii) an immunocompromised patient chronically shedding NoV. When a quantitative yeast two-hybrid assay was used, VP2 was found to interact with VP1 in a time-ordered, strain-dependent manner among 3 NoV GII.4 strains. Our findings suggest that VP1 and VP2 may covary in virus evolution and that sequence hypervariability of VP2 may be functionally driven. Further investigations are warranted.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: